Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized double-blind vehicle-controlled study of HSK44459 cream in healthy volunteers and patients with plaque psoriasis
CTR20262085Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK44459 in plaque psoriasis, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Jun 2026; status: active.
02
Drugs
HSK44459
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20262085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262085.